Mass General rolls out clinical trial imaging tool powered by Blackford Analysis

Boston, MA and Edinburgh, UK – November 11, 2014 – Blackford Analysis, a provider of software products that accelerate comparison of medical images, today announced that its software has been successfully integrated into a tool developed by Massachusetts General Hospital’s Tumor Imaging Metrics Core for its Precision Imaging Metrics system that helps radiologists and oncologists coordinate to generate clinical trial imaging results with enhanced efficiency and quality.

“We developed our Precision Imaging Metrics Manager technology through our Tumor Imaging Metrics Core (TIMC) to optimize quality and accelerate clinical trial imaging for the five Harvard hospitals of the Dana-Farber/Harvard Cancer Center (DF/HCC) and are now providing other Cancer Centers with the same system,” said Dr. Gordon J. Harris, co-Director of the Tumor Imaging Metrics Core at Massachusetts General Hospital, and Professor of Radiology, Harvard Medical School. “Having tools integrated into our system to quickly register medical images across time provides us with enhanced accuracy and efficiency for ensuring quality.”

The Precision Imaging Metrics team has implemented Blackford’s MatchedCrosshairs functionality, which enables radiologists to simply click on a location in any scan to instantly bring up the same location on multiple scans from different times and/or different modalities (e.g. CT with MRI), all with a single click.

In addition to internal use, the Mass General’s Precision Imaging Metrics system with the integrated Blackford registration tool has also been rolled out to Cancer Centers at Yale University and the University of Washington in Seattle, and is in the process of being implemented at the Huntsman Cancer Institute at the University of Utah.

“The system for managing clinical trials workflow and tumor measurement tracking developed by our colleagues at Massachusetts General Hospital has improved our accuracy and efficiency for tumor metrics, benefitting our oncology physicians and patients,” said Dr. Carolyn L. Wang, Body Imaging Director at the Seattle Cancer Care Alliance, and Assistant Professor in Radiology, University of Washington. “The tool provided for registering images across time with one click is one of many features in their system that accelerates our assessments and assures quality for our clinical trials metrics.”

“We are delighted that our relationship with Mass General’s Tumor Imaging Metrics Core and their Precision Imaging Metrics system has resulted in more implementations of our technology in hospital departments across the US,” said Dr. Ben Panter, CEO, Blackford Analysis. “All our products can be easily integrated into any image viewer environment, delivering a range of benefits to the clinician and providing OEMs with a key competitive advantage.”

Blackford Analysis will be showing its full range of capabilities at RSNA 2014 at booth 1506 in the South Hall. To request a meeting with Blackford, please visit www.blackfordanalysis.com/event/rsna-2014/.

To request a meeting with Intelerad at RSNA 2014, please visit http://rsna.intelerad.com.

About Blackford Analysis                                                                    
Blackford Analysis is a developer of software solutions for the medical sector. The company develops software designed to accelerate medical image comparison – saving time and increasing clinician capacity. Founded in 2010, and with operations in the United Kingdom and the United States, Blackford Analysis is backed by Archangel Informal Investment, one of the UK’s leading business angel syndicates. For more information, visit www.blackfordanalysis.com